fbpx

Xstrahl to Highlight Dual Modality Treatment Solution for Dermatologists at AOCD

April 8, 2024

Xstrahl to Highlight Dual Modality Treatment Solution for Dermatologists at AOCD 
Radiant™ Aura is a painless non-surgical office-based radiation therapy treatment options for patients with non-melanoma skin cancers and keloid scarring
 

Radiant Aura is the only dual modality surface radiation therapy system that enables you to choose either electronic brachytherapy or SRT based on the needs of your patients.

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the AOCD 2024 Spring New Trends in Dermatology Meeting, April 11-14, 2024, in Scottsdale, AZ.

“We’re pleased to highlight Radiant Aura at this year’s AOCD meeting. Radiant Aura is a low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring. It is the only dual modality system that offers both non-invasive electronic brachytherapy (eBt) and superficial radiation therapy (SRT) for NMSC and keloid scarring,” said Adrian Treverton, CEO of Xstrahl.

Radiant Aura is a painless non-surgical skin cancer treatment alternative available to support the delivery of office-based radiation therapy for patients with NMSC when surgery is not possible, contraindicated, or simply not preferred due to cosmetic concerns. The device received U.S. Food and Drug Administration (FDA) 510(k) clearance in July 2023.

Visit Xstrahl at AOCD 2024, booth # 22 at the Westin Kierland from April 11-14, 2024.

# # #

For further information, please contact:
Kelly Withers, National Sales Director
Cell: 602-509-4990 or e-mail: kellywithers@xstrahl.com

About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.

To learn more about Radiant Aura, visit www.xstrahl.com/aocd2024
To learn more about all Xstrahl clinical and research systems, visit www.xstrahl.com

 

 

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts